Center on Emerging and Zoonotic Infectious Diseases (CEZID) Phase 2
Official title: Center on Emerging and Zoonotic Infectious Diseases Phase 2
Funded at Kansas State University · NIH-11336277 · Data updated 2026-11-12
A national center at Kansas State University continues to build research on high-impact infectious diseases that jump from animals to people and improve how scientists work together.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kansas State University NIH-funded |
| Lab location | 1 site (Manhattan, United States) |
| Project start | June 1, 2020 |
| Project end | April 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $2,270,641 |
| NIH project number | 2P20GM130448-06 |
| Project ID | NIH-11336277 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to patients directly; research strengthens knowledge and tools that may benefit patients in the future.
✕Less likely to help
As a center-focused grant, individuals without interest in infectious disease research careers or related trials may not directly benefit.
What this research studies
This grant supports CEZID’s expansion of research on emerging and zoonotic pathogens, focusing on virulence factors and how hosts interact with pathogens. It funds two core facilities and four main research projects to push findings toward independent funding and real-world impact. The program also emphasizes workforce development and pilot projects to cultivate new investigators in the field. The aim is to strengthen regional and national capacity to prevent and control dangerous infectious diseases.
Why it matters
Potential benefit: Could accelerate the development of better diagnostics, treatments, and prevention strategies for emerging infectious diseases.
How similar studies have gone: Phase 1 demonstrated progress and the pilot program helped advance investigators toward independent funding, suggesting potential for Phase 2 success.
Where this research is happening
-
Kansas State University
Manhattan, United States Active
Researchers
- Principal investigator: Richt, Juergen a — Kansas State University
- Study coordinator: Richt, Juergen a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.